Intelligence / Healthtech / PMA Approvals / Dilon Technologies, INC.
Approvalsdevice change approved (PMA)3 Sept 2026
Dilon Technologies, INC.
3 Sept 2026: Device change approved (PMA) · HEMOBLAST Bellows. Recorded in the openFDA device PMA data.
- Decided
- 3 Sept 2026
- Device
- HEMOBLAST Bellows
- Specialty
- General, Plastic Surgery
- Type
- Supplement (Normal 180 Day Track No User Fee)
- Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Reference
- P170012 S032
- Location
- Newport News, VA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Dilon Technologies, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General, Plastic Surgery
PMA Approvals
7 NovBaxter Healthcare Corporationdevice change approved (PMA) · PerClot Absorbable Hemostatic Powder Accessory TipsApprovals4 NovAllergandevice change approved (PMA) · Juvéderm Ultra XC; Juvéderm Ultra Plus XCApprovals4 NovMerz North America, INC.device change approved (PMA) · Belotero Volume (+) LidocaineApprovals4 NovTiger Aesthetics Medical, LLCdevice change approved (PMA) · Sientra® Silicone Gel Breast ImplantsApprovals23 OctAdvanced Medical Solutions Limiteddevice change approved (PMA) · LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation DeviceApprovals8 OctCroma-Pharma GMBHdevice change approved (PMA) · saypha® ChiQApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.